share_log

樂氏國際控股：截至2023年12月31日止年度 年度業績公告

YUES INTL HLDG: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023

香港交易所 ·  Mar 27 10:10
Summary by Moomoo AI
乐氏国际控股集团有限公司公布截至2023年12月31日止年度業績，收益約人民幣133.9百萬元，較上年度減少約25.4%。年度虧損約人民幣34.2百萬元，每股基本虧損約為人民幣3.28分。主要業務包括運輸、倉儲、廠內物流及定製服務，受到市場需求減少、運營成本增加等因素影響。公司於2023年10月收購中山海慧科企物流（集團）有限公司60%股權，以增強市場主導地位及營運效率。董事會不建議派付本年度末期股息。公司將繼續探索新業務機會，包括中醫藥相關業務，以實現可持續增長。
乐氏国际控股集团有限公司公布截至2023年12月31日止年度業績，收益約人民幣133.9百萬元，較上年度減少約25.4%。年度虧損約人民幣34.2百萬元，每股基本虧損約為人民幣3.28分。主要業務包括運輸、倉儲、廠內物流及定製服務，受到市場需求減少、運營成本增加等因素影響。公司於2023年10月收購中山海慧科企物流（集團）有限公司60%股權，以增強市場主導地位及營運效率。董事會不建議派付本年度末期股息。公司將繼續探索新業務機會，包括中醫藥相關業務，以實現可持續增長。
Lech International Holdings Group Limited announced its results for the year ended 31 December 2023 with revenues of approximately RMB133.9 million, down approximately 25.4% year-on-year. The annual loss was approximately RMB34.2 million and the basic loss per share was approximately RMB3.28 cents. Major businesses, including transportation, warehousing, in-plant logistics and custom services, are affected by reduced market demand and increased operating costs. In October 2023, the Company acquired a 60% stake in Zhongshan Hai HuiTech Logistics (Group) Co., Ltd., to enhance its market dominance and operational efficiency. The Board of Directors does not propose the payment of a dividend at the end of the year. The Company will continue to explore new business opportunities, including Chinese Pharma-related businesses, to achieve sustainable growth.
Lech International Holdings Group Limited announced its results for the year ended 31 December 2023 with revenues of approximately RMB133.9 million, down approximately 25.4% year-on-year. The annual loss was approximately RMB34.2 million and the basic loss per share was approximately RMB3.28 cents. Major businesses, including transportation, warehousing, in-plant logistics and custom services, are affected by reduced market demand and increased operating costs. In October 2023, the Company acquired a 60% stake in Zhongshan Hai HuiTech Logistics (Group) Co., Ltd., to enhance its market dominance and operational efficiency. The Board of Directors does not propose the payment of a dividend at the end of the year. The Company will continue to explore new business opportunities, including Chinese Pharma-related businesses, to achieve sustainable growth.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more